OTC - ACTIVE INGREDIENT SECTION
aloe, glycerin
aloe, glycerin
butylene glycol, water, niacinamide, adlay fermented extract, etc
improve on acne, stopic dermatitis, and effects on burn treatment, skin soothing
keep out of reach of the children
after cleansing thoroughly, moisten 1~2g in cotton or sterilized gauze and attached to the affected area for 20~30 minutes to absorb enough contents
do not swallow it
do not use on wounded skin
do not use allergic skin types
for topical use only
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 73158-0001-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-5a24-a910-e053-dadaa90a0b85 | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73158-0001-1 | ATOPIM | 100 g in 1 BOTTLE | LIQUID | 100 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 73158-0001 | ATOPIM (FERMENTED ENXYME EXTRACT OF ALOE. GLYCERIN) LIQUID [HI TECHNOLOGY] | 1 | Legacy NDC, 1 package rows | 20190611_8b01b776-cc0f-7d85-e053-2995a90ae626.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73158-0001 | 73158-0001-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GLYCERIN | PDC6A3C0OX | ACTIB |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| NIACINAMIDE | 25X51I8RD4 | IACT |
| ALOE | V5VD430YW9 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8b00e806-89d2-7385-e053-2a95a90a718c | 8b01b776-cc0f-7d85-e053-2995a90ae626 | 2019-06-10 | Warnings | 8b00e806-89d2-7385-e053-2a95a90a718c 8b01b776-cc0f-7d85-e053-2995a90ae626 |
Adverse event summaries are temporarily unavailable. Other product information remains available.